drugset / Trial / NCT07324018
Spirulina Derivative for Radiation Esophagitis
RandomizedParallel-groupQuadruple-blindPrevention
Summary
To evaluate the efficacy and safety of a Spirulina-derived product in preventing and treating radiation-induced esophagitis in esophageal cancer patients undergoing intensity-modulated radiotherapy (IMRT).
Timeline
- Start
- 2026-01-12
- Primary completion
- 2026-06-30
- Completion
- 2026-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | spirulina-derived exosomes | Unknown | — | Oral |
Indications
No indication recorded.